This study reviews the effectiveness of PPS-23 vaccines in preventing invasive pneumococcal disease and pneumonia from all causes among adults more than 65 years of age or with chronic health problems.
Updated: January 25, 2006 | Read full article...
This study shows that introduction of the conjugate pneumococcal vaccine reduced the incidence of invasive pneumococcal disease and eliminated racial differences in the incidence rates of the disease in young children in Tennessee.
Updated: June 3, 2008 | Read full article...
This study shows that pneumococcal vaccine (PCV7) has been effective in decreasing pneumococcal infections, which cause ear infections, sinus infections, pneumonia requiring hospitalization, and bacterial meningitis.
Updated: July 7, 2004 | Read full article...
This study shows the effect of the vaccination program for young children against pneumococcal disease in the population of a large HMO: decrease in the incidence of the disease and decrease in antibiotic-resistant pneumococci.
Updated: July 14, 2004 | Read full article...
This study identified the types of adverse events reported to the Vaccine Adverse Events Reporting System after vaccination with the 7-valent pneumococcal vaccine (PCV7) and assesed those that warranted further investigation.
Updated: August 3, 2005 | Read full article...
PCV7 vaccination of young children has resulted not only in lower rates of invasive pneumococcal disease but also a lower proportion of strains which are resistant to antibiotic in children less than as well as in persons older than 2 years of age.
Updated: January 12, 2005 | Read full article...
A number of bacteria cause ear infections in children. Some of these children require a surgical procedure called tympanostomy tube placement. This study shows that the PCV7 immunization reduced the number of these surgeries.
Updated: June 3, 2008 | Read full article...
This study shows that the recommendation for universal PCV7 vaccination has resulted in a decline of childhood invasive pneumococcal disease in Massachusetts.
Updated: March 30, 2005 | Read full article...
In the past, the incidence of invasive pneumococcal disease has been higher among blacks than among whites in the United States. Pneumococcal vaccine has reduced this disparity.
Updated: June 16, 2004 | Read full article...
This study evaluates whether prior immunization with the 23-valent pneumococcal polysaccharide vaccine improves clinical outcomes among adult patients hospitalized with community-acquired pneumonia.
Updated: April 17, 2006 | Read full article...